
Sign up to save your podcasts
Or


A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodies. We also discuss the critical role of clinical trials in shaping the future of CTCL care.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by Kyowa Kirin, Inc.
The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with Blood Cancer United Podcast.
By Blood Cancer UnitedA Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodies. We also discuss the critical role of clinical trials in shaping the future of CTCL care.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by Kyowa Kirin, Inc.
The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with Blood Cancer United Podcast.